Self-reported quality of life predicts mortality 7 years post implant in patients with an implantable cardioverter defibrillator

Christina Maar Andersen, Barbara van Veen, Dominic A M J Theuns, Susanne S. Pedersen

Research output: Contribution to journalConference abstract in journalCommunication

Abstract

Background: An implantable cardioverter defibrillator (ICD) is a device used to treat life-threatening arrhythmias and prevent sudden cardiac death. The ICD can reduce the rate of all-cause mortality by 37%. Although the device has obvious medical benefits, the device also poses some challenges e.g. lead fractures and appropriate/inappropriate shocks. On top of this, patients have to deal with their underlying disease and may also have co-morbidities. These challenges can impact the patients’ well-being and quality of life (QoL). Studies have shown that QoL can predict mortality at 1-year follow-up. However, there is currently no knowledge of the long-term effects of QoL on mortality in patients with an ICD.

Purpose: To examine whether self-rated QoL at the time of implantation predicts mortality at 7 years follow up in patients with an ICD.

Methods: The sample consist of 392 patients (80% men; mean (SD) age=58 (12) consecutively implanted between 2003 and 2010. Patients completed the SF-36. The eight subscales and the physical and mental component summary scores were used as predictors of mortality 7 years post implant.

Results: At 7-year follow-up, 33.7% (132/392) of the patients had died. Patients with low QoL had an increased risk of mortality 7 years after implant. The QoL subscales physical functioning, role physical functioning, and vitality were associated with an increased risk of mortality (Table 1).

Conclusion: Patients with poor QoL on the domains of physical functioning, role physical functioning and vitality at the time of implant were more likely to have died at 7 years’ follow-up as compared to patients with good QoL on these domains. An assessment of the patients’ QoL at time of implant could help to identify patients at increased risk of mortality.
Original languageEnglish
JournalEuropean Journal of Cardiovascular Nursing
Volume17
Issue number1 Suppl.
Pages (from-to)77
Number of pages1
ISSN1474-5151
DOIs
Publication statusPublished - 8. Jun 2018
EventEuroHeartCare 2018: Tackling the Complexity of Cardiovascular Care - Trinity College Dublin, Dublin, Ireland
Duration: 7. Jun 20189. Jun 2018
https://www.escardio.org/Congresses-%26-Events/EuroHeartCare

Conference

ConferenceEuroHeartCare 2018
LocationTrinity College Dublin
CountryIreland
CityDublin
Period07/06/201809/06/2018
Internet address

Fingerprint

Implantable Defibrillators
Quality of Life
Equipment and Supplies

Keywords

  • Implantable cardioverter defibrillator
  • Mortality
  • Quality of Life

Cite this

@article{82a9fc01640743eabd8725f6657a2ff3,
title = "Self-reported quality of life predicts mortality 7 years post implant in patients with an implantable cardioverter defibrillator",
abstract = "Background: An implantable cardioverter defibrillator (ICD) is a device used to treat life-threatening arrhythmias and prevent sudden cardiac death. The ICD can reduce the rate of all-cause mortality by 37{\%}. Although the device has obvious medical benefits, the device also poses some challenges e.g. lead fractures and appropriate/inappropriate shocks. On top of this, patients have to deal with their underlying disease and may also have co-morbidities. These challenges can impact the patients’ well-being and quality of life (QoL). Studies have shown that QoL can predict mortality at 1-year follow-up. However, there is currently no knowledge of the long-term effects of QoL on mortality in patients with an ICD. Purpose: To examine whether self-rated QoL at the time of implantation predicts mortality at 7 years follow up in patients with an ICD. Methods: The sample consist of 392 patients (80{\%} men; mean (SD) age=58 (12) consecutively implanted between 2003 and 2010. Patients completed the SF-36. The eight subscales and the physical and mental component summary scores were used as predictors of mortality 7 years post implant.Results: At 7-year follow-up, 33.7{\%} (132/392) of the patients had died. Patients with low QoL had an increased risk of mortality 7 years after implant. The QoL subscales physical functioning, role physical functioning, and vitality were associated with an increased risk of mortality (Table 1). Conclusion: Patients with poor QoL on the domains of physical functioning, role physical functioning and vitality at the time of implant were more likely to have died at 7 years’ follow-up as compared to patients with good QoL on these domains. An assessment of the patients’ QoL at time of implant could help to identify patients at increased risk of mortality.",
keywords = "Implantable cardioverter defibrillator, Mortality, Quality of Life",
author = "Andersen, {Christina Maar} and Veen, {Barbara van} and Theuns, {Dominic A M J} and Pedersen, {Susanne S.}",
year = "2018",
month = "6",
day = "8",
doi = "10.1177/1474515118787764",
language = "English",
volume = "17",
pages = "77",
journal = "European Journal of Cardiovascular Nursing",
issn = "1474-5151",
publisher = "SAGE Publications",
number = "1 Suppl.",

}

Self-reported quality of life predicts mortality 7 years post implant in patients with an implantable cardioverter defibrillator. / Andersen, Christina Maar; Veen, Barbara van; Theuns, Dominic A M J; Pedersen, Susanne S.

In: European Journal of Cardiovascular Nursing, Vol. 17, No. 1 Suppl., 08.06.2018, p. 77.

Research output: Contribution to journalConference abstract in journalCommunication

TY - ABST

T1 - Self-reported quality of life predicts mortality 7 years post implant in patients with an implantable cardioverter defibrillator

AU - Andersen, Christina Maar

AU - Veen, Barbara van

AU - Theuns, Dominic A M J

AU - Pedersen, Susanne S.

PY - 2018/6/8

Y1 - 2018/6/8

N2 - Background: An implantable cardioverter defibrillator (ICD) is a device used to treat life-threatening arrhythmias and prevent sudden cardiac death. The ICD can reduce the rate of all-cause mortality by 37%. Although the device has obvious medical benefits, the device also poses some challenges e.g. lead fractures and appropriate/inappropriate shocks. On top of this, patients have to deal with their underlying disease and may also have co-morbidities. These challenges can impact the patients’ well-being and quality of life (QoL). Studies have shown that QoL can predict mortality at 1-year follow-up. However, there is currently no knowledge of the long-term effects of QoL on mortality in patients with an ICD. Purpose: To examine whether self-rated QoL at the time of implantation predicts mortality at 7 years follow up in patients with an ICD. Methods: The sample consist of 392 patients (80% men; mean (SD) age=58 (12) consecutively implanted between 2003 and 2010. Patients completed the SF-36. The eight subscales and the physical and mental component summary scores were used as predictors of mortality 7 years post implant.Results: At 7-year follow-up, 33.7% (132/392) of the patients had died. Patients with low QoL had an increased risk of mortality 7 years after implant. The QoL subscales physical functioning, role physical functioning, and vitality were associated with an increased risk of mortality (Table 1). Conclusion: Patients with poor QoL on the domains of physical functioning, role physical functioning and vitality at the time of implant were more likely to have died at 7 years’ follow-up as compared to patients with good QoL on these domains. An assessment of the patients’ QoL at time of implant could help to identify patients at increased risk of mortality.

AB - Background: An implantable cardioverter defibrillator (ICD) is a device used to treat life-threatening arrhythmias and prevent sudden cardiac death. The ICD can reduce the rate of all-cause mortality by 37%. Although the device has obvious medical benefits, the device also poses some challenges e.g. lead fractures and appropriate/inappropriate shocks. On top of this, patients have to deal with their underlying disease and may also have co-morbidities. These challenges can impact the patients’ well-being and quality of life (QoL). Studies have shown that QoL can predict mortality at 1-year follow-up. However, there is currently no knowledge of the long-term effects of QoL on mortality in patients with an ICD. Purpose: To examine whether self-rated QoL at the time of implantation predicts mortality at 7 years follow up in patients with an ICD. Methods: The sample consist of 392 patients (80% men; mean (SD) age=58 (12) consecutively implanted between 2003 and 2010. Patients completed the SF-36. The eight subscales and the physical and mental component summary scores were used as predictors of mortality 7 years post implant.Results: At 7-year follow-up, 33.7% (132/392) of the patients had died. Patients with low QoL had an increased risk of mortality 7 years after implant. The QoL subscales physical functioning, role physical functioning, and vitality were associated with an increased risk of mortality (Table 1). Conclusion: Patients with poor QoL on the domains of physical functioning, role physical functioning and vitality at the time of implant were more likely to have died at 7 years’ follow-up as compared to patients with good QoL on these domains. An assessment of the patients’ QoL at time of implant could help to identify patients at increased risk of mortality.

KW - Implantable cardioverter defibrillator

KW - Mortality

KW - Quality of Life

U2 - 10.1177/1474515118787764

DO - 10.1177/1474515118787764

M3 - Conference abstract in journal

C2 - 30056752

VL - 17

SP - 77

JO - European Journal of Cardiovascular Nursing

JF - European Journal of Cardiovascular Nursing

SN - 1474-5151

IS - 1 Suppl.

ER -